Overview

Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
0
Participant gender:
All
Summary
This is an open label trial for patients currently enrolled in other perifosine trials.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
AEterna Zentaris
Treatments:
Tamoxifen
Trastuzumab
Criteria
Inclusion Criteria:

- Patients must be currently receiving treatment with perifosine on a previously
approved protocol.

- Patients must have had at least one evaluation following the initiation of treatment
and have stable disease, partial response or complete response.

- Patient is willing to sign a new consent Regarding the protocol no exclusion criteria
are described.